Endoscopy in CKD With Iron Deficiency Anemia
Value of Esophageogastroduodenscopy in Assessment of Chronic Kidney Disease Patients With Iron Deficiency Anemia Without Gastrointestinal Symptoms
1 other identifier
interventional
81
1 country
1
Brief Summary
Iron deficiency anemia is very common in CKD patients. Data about gastrointestinal lesions in Arab patients are insufficient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2021
CompletedFirst Submitted
Initial submission to the registry
February 4, 2022
CompletedFirst Posted
Study publicly available on registry
February 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2022
CompletedJanuary 5, 2024
January 1, 2024
11 months
February 4, 2022
January 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of upper gastrointestinal endoscopic findings In chronic kidney disease patients with iron deficiency anemia
Detect rate of upper GIT lesions in asymptomatic CKD patients with iron deficiency anemia using endoscopy followed by biopsy and histopathological examination
6 months
Study Arms (2)
Group 1
PLACEBO COMPARATORChronic kidney diseases patients with iron deficiency anemia and eGFR ≥ 60 ml/min/1.73 m2
Group 2
EXPERIMENTALChronic kidney diseases patients with iron deficiency anemia and eGFR \< 60 ml/min/1.73 m2.
Interventions
Upper gastrointestinal endoscpy for all participants and gastric biopsy for histopathological examination for suspicious lesions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
Zagazig university
Zagazig, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Lecturer internal medicine
Study Record Dates
First Submitted
February 4, 2022
First Posted
February 15, 2022
Study Start
May 1, 2021
Primary Completion
March 15, 2022
Study Completion
April 15, 2022
Last Updated
January 5, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share